The dopamine receptor D1 gene and ADHD: A piece of the genetic puzzle?

Attention-deficit/hyperactivity disorder (ADHD) is recognized as the most prevalent mental health disorder of childhood, affecting about 3 to 5 percent of school-age children worldwide. The hallmarks of the disorder are age-inappropriate levels of inattention, hyperactivity and impulsiveness. These problems often lead to underachievement in school and can have a negative impact on interpersonal relationships and on self-esteem. ADHD symptoms often persist into adolescence and adulthood, resulting in lifelong difficulties in academic, occupational, social and family functioning. In addition, there is evidence that ADHD may be a risk factor for other serious mental health problems and specific learning disabilities. All told, ADHD is a major public health issue.

Twin, family and adoption studies have produced strong evidence that ADHD is, in large part, genetically determined. Inheritance of the disorder is complex. Multiple genes, each of small to moderate effect, are likely to be involved. Although the neurobiological basis of ADHD remains to be fully understood, there is much evidence pointing to dysregulation of the dopamine neurotransmitter system as an underlying factor. Because of this, genes of the dopamine system are considered as candidates for involvement in the disorder. Genes that have been investigated are the ones encoding the five receptors in the brain, D1D5, through which dopamine acts. Such studies, to date, have found strong evidence for the involvement of two of these receptor genes, those encoding the D4 and D5 receptors, but little or no evidence for the involvement of either D2 or D3. Recently, the authors obtained evidence for involvement of the remaining member of this class of genes, the gene encoding dopamine receptor D1 (DRD1).

Combined evidence from a number of human and animal studies suggested DRD1 to be a particularly strong candidate for involvement in susceptibility to ADHD. To test this, the authors i

Contact: Aimee Midei
Molecular Psychiatry

Page: 1 2

Related biology news :

1. Vollum scientists find new form of dopamine transmission
2. How amphetamine affects the dopamine transporter
3. Drug-naive schizophrenia: The dopamine connection
4. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
5. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
6. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
7. Two-pronged attack targeting EGF receptor hinders cancer cell growth
8. Tamoxifen stimulates breast cancer growth following alteration of estrogen receptor
9. Dioxin-receptor network identified
10. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic
11. Scientists at Scripps Research Institute describe structure of receptor on surface of 1918 flu virus

Post Your Comments:

(Date:8/21/2019)... ... August 20, 2019 , ... ... bioactive technologies for the spine, today announced the 510(K) clearance of its novel ... modification that is proven to improve osseointegration through superior hydrophilicity and optimized surface ...
(Date:8/19/2019)... ... August 19, 2019 , ... Since ... use of ultra-thin two dimensional slices which are placed on microscope slides, stained ... complex tissues and complicated features such as vasculature and thus researchers in the ...
(Date:8/15/2019)... , ... August 15, 2019 , ... ... Now what? As serialization mandates become increasingly complex, and aggregation becomes fully applied ... serialization software is the best long-term solution. , Until now, most regulations?including the ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from ... of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The ... peak, change in crystallite size , Over 142% increase in particle size ...
(Date:6/18/2019)... , ... June 18, 2019 , ... Personalized Stem ... New Drug (IND) application to the FDA for use of a person’s own adipose-derived ... a treatment of osteoarthritis in the knee. This IND is the first of ...
(Date:6/11/2019)... MONTREAL (PRWEB) , ... June 10, 2019 , ... ... growth of its distribution network with the appointment of Biofeedback Tech Ltd ... physiological monitoring systems are an essential part of many therapeutic treatments and clinical ...
(Date:6/11/2019)... ... June 10, 2019 , ... DeepDyve ... its scientific journals to DeepDyve’s rental service for peer-reviewed journals. , IOPP’s ... of more than 20 million articles, sourced from more than 15,000 journals. , ...
Breaking Biology Technology:
Cached News: